Related Experiment Video
Updated: Jun 23, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Advancements in Technologies Targeting Horizontal Gene TransferRoutes to Control Drug Resistance Evolution.
Samuel Chetachukwu Adegoke1, Md Adnan Karim1, Maurelio Cabo Jr1
1Department of Nanoscience, Joint School of Nanoscience and Nanoengineering, E Gate City Blvd, Greensboro, North Carolina 27401, United States.
Multidrug-resistant bacteria spread rapidly through horizontal gene transfer (HGT). New strategies like synthetic competence inhibitors and CRISPR-Cas can block HGT, slowing resistance evolution and preserving antibiotic effectiveness.
Area of Science:
- Microbiology
- Genetics
- Public Health
Background:
- The rise of multidrug-resistant (MDR) bacteria is a global health crisis.
- Antibiotic resistance genes spread rapidly via horizontal gene transfer (HGT), challenging modern medicine.
- Traditional antibiotic development cannot keep pace with bacterial resistance evolution.
Purpose of the Study:
- To review the current understanding of HGT in antibiotic resistance spread.
- To explore novel strategies for controlling HGT and mitigating antimicrobial resistance.
- To discuss the potential and challenges of translating these strategies into practice.
Main Methods:
- Review of current scientific literature on HGT mechanisms and resistance spread.
- Analysis of emerging technologies targeting HGT, including synthetic competence inhibitors, AOPs, CRISPR-Cas, gene drives, and antiplasmids.
- Evaluation of the potential for these strategies to disrupt horizontal gene flow and slow resistance evolution.
Main Results:
- HGT is a primary driver of antibiotic resistance dissemination.
- Several novel strategies show promise in laboratory settings for blocking HGT.
- These include synthetic competence inhibitors, advanced oxidation processes (AOPs), CRISPR-Cas technologies, gene drives, and antiplasmids.
- Challenges exist in translating these promising laboratory findings into clinical and environmental applications.
Conclusions:
- Targeting HGT offers a proactive approach to combatting MDR infections.
- Blocking HGT can complement existing antimicrobial stewardship and therapies.
- Further research is crucial for developing scalable solutions to manage MDR infections by targeting resistance acquisition mechanisms.
Related Concept Videos
Development of Antibiotic Resistance
Types of Genetic Transfer Between Organisms
Antibiotic Selection
Horizontal Gene Transfer
Mechanism of Antibiotic Resistance in MRSA
Transformation

